Description du projet
Un apport optimal en sodium pour réduire le risque de maladie cardiovasculaire
L’hypertension, l’un des principaux facteurs de risque de maladie cardiovasculaire (MCV) dans le monde, est influencée par l’apport en sodium (sel). Cependant, le niveau optimal d’apport en sodium associé au risque le plus faible de MCV reste incertain, et on ignore si les niveaux optimaux varient en fonction des populations et des individus. Le projet COSIP, financé par l’UE, a été lancé pour répondre à ces questions. Le projet déterminera si un apport soutenu (à long terme) en sodium est associé à des effets bénéfiques sur des biomarqueurs cardiovasculaires établis et nouveaux et si l’association entre l’apport en sodium et les maladies cardiovasculaires varie en fonction de l’origine ethnique, du sexe, de l’âge et d’autres facteurs alimentaires. Le projet quantifiera la fraction de l’apport excessif en sodium attribuable à la population et déterminera si l’apport en sodium est associé à d’autres conditions cliniques liées au système vasculaire.
Objectif
Hypertension is a leading risk factor for cardiovascular disease (CVD) globally, accounting for 25-35% of the population-attributable fraction. Sodium (salt) intake is a key determinant of blood pressure, and reducing sodium intake has emerged as an important target for population-based interventions to prevent CVD. However, there is considerable uncertainty about the optimal level of sodium (salt) intake that is associated with lowest CVD risk, and whether optimal levels differ for different populations and individuals. In this proposal, we will answer key fundamental research questions about the association of sodium intake with blood pressure and CVD risk. Our research challenges current guideline recommendations of low-sodium intake for all populations. Specifically, we will: a) determine whether sustained (long-term) low sodium intake is associated with beneficial (or adverse) effects on established and novel CV biomarkers. b) explore whether inter-daily ‘pattern’ of sodium intake is an important determinant of 24-hour blood pressure pattern; c) determine whether the association between sodium intake and CVD varies by ethnicity, sex, age, other dietary factors (e.g. potassium intake), or other factors in 2 large international epidemiologic studies (PURE and INTERSTROKE; n>125,000 individuals). d) quantify the population-attributable fraction of excess sodium intake on global burden of CVD (stroke, myocardial infarction, heart failure and CV death), and model the potential impact of various population-based approaches to reducing sodium intake; e) determine whether sodium intake is associated with other vascular-related clinical conditions, namely including atrial fibrillation, cognitive impairment and falls (providing novel information); f) determine whether genetic variants associated with ‘salt sensitivity’ and hypertension are association with blood pressure and stroke, and whether these associations are modified by sodium intake.
Champ scientifique
Programme(s)
Thème(s)
Régime de financement
ERC-STG - Starting GrantInstitution d’accueil
H91 Galway
Irlande